Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Pier Edoardo Rovatti"'
Autor:
Pier Edoardo Rovatti, Marco Punta, Matteo Maria Naldini, Matteo Barcella, Laura Zito, Matteo Giovanni Carrabba, Massimo Bernardi, Jacopo Peccatori, Ivan Merelli, Bernhard Gentner, Fabio Ciceri, Luca Vago, Cristina Toffalori
Publikováno v:
HemaSphere, Vol 7, p e908160d (2023)
Externí odkaz:
https://doaj.org/article/e87adfa2d3ba42719a1fd7dcb0505a22
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Over the last decade, the development of multiple strategies to allow the safe transfer from the donor to the patient of high numbers of partially HLA-incompatible T cells has dramatically reduced the toxicities of haploidentical hematopoietic cell t
Externí odkaz:
https://doaj.org/article/f7f3e159ce3945388ae637cd8cf85315
Autor:
Bettina Brauchle, Pier Edoardo Rovatti, Fabio Ciceri, Eleonora Draghi, Anetta Marcinek, Marion Subklewe, Mattia Di Bono, Cristina Toffalori, Cesare Covino, Karl-Peter Hopfner, Laura Zito, Massimo Bernardi, Luca Vago, Matteo Carrabba, Monika Herrmann
Publikováno v:
Blood. 134:513-513
Background Genomic loss of mismatched HLAs ("HLA loss") represents a frequent modality by which acute myeloid leukemia (AML) evades immune recognition from donor T cells after partially HLA-incompatible allogeneic hematopoietic cell transplantation (
Autor:
Pier Edoardo Rovatti, Antje-Christine Walz, Christian Gassner, Pablo Umana, Michael von Bergwelt-Baildon, Nikola P. Konstandin, Angélique Augustin, Binje Vick, John Challier, Estelle Marrer-Berger, Wei Xu, Jigar Patel, Marc Schmitz, Christina Krupka, Jörg Benz, Lydia Jasmin Hanisch, Karsten Spiekermann, Gerulf Hänel, Christian Klein, Maurine Rothe, Vesna Pulko, Antje Tunger, Felix S Lichtenegger, Katharina Hunt, Alejandro Carpy, Emmanuelle Lezan, Axel Ducret, Alexander Bujotzek, Christian Augsberger, Marion Subklewe, Daniela Ortiz-Franyuti, Anne Schönle, Victor Lyamichev, Luca Vago, Irmela Jeremias, Johannes Sam
Publikováno v:
Blood
Antibody-based immunotherapy is a promising strategy for targeting chemoresistant leukemic cells. However, classical antibody-based approaches are restricted to targeting lineage-specific cell surface antigens. By targeting intracellular antigens, a